Učitavanje...
Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India
The burden of chronic liver disease (CLD) in India is high, particularly among middle-aged men, with nearly 220,000 deaths due to cirrhosis in 2017. CLD increases the risk of infection, severe disease (e.g. hepatitis A virus or HAV superinfection, acute-on-chronic liver failure, fulminant hepatic fa...
Spremljeno u:
| Izdano u: | Hum Vaccin Immunother |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8078677/ https://ncbi.nlm.nih.gov/pubmed/33236963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1832408 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|